Samir El Abdouni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Samir El Abdouni has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Floor van Rosse
Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
3 shared publications - Laura Kalfsvel
Department of Hospital Pharmacy, Erasmus MC, University Medical Center, Rotterdam, the Netherlands
3 shared publications Floor van Rosse
Department of Hospital Pharmacy, Erasmus MC University Medical Center Rotterdam The Netherlands
2 shared publications- Paul-Hugo Marie van der Kuy
Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, Netherlands
2 shared publications - Robert Bernard Flint
Department of Hospital Pharmacy Erasmus University Medical Centre Rotterdam the Netherlands
2 shared publications - Sinno H. P. Simons
Division of Neonatology, Department of Neonatal and Paediatric Intensive Care, Erasmus UMC, Rotterdam, The Netherlands
2 shared publications
Latest Publications
- Open Access
- 20 August 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Usability and user experience of an educational electronic prescribing system to train medical students: a mixed-methods approach
Background: Prescribing is a core responsibility of physicians, with electronic (e-)prescribing becoming the global standard. However, e-prescribing is insufficiently integrated in medical curricula, creating a gap between education and actual practice. To address this, we developed Edups, an educational electronic prescribing system that enables medical students to practice prescribing safely in a realistic environment. This study evaluated the usability and user experience of Edups among medical students in a real-world educational setting. Methods: A prospective mixed-methods pilot study was conducted among first- and final-year master’s medical students at Erasmus MC University Medical Center (the Netherlands) from October 2023 to April 2024. In total, 136 students were invited to participate in our study after using Edups during two pharmacotherapy classes. Participants were invited to complete the System Usability Scale (SUS; 5-point Likert scale; 0-100) survey and participate in semi-structured interviews. Data were analyzed using descriptive statistics and inductive thematic analysis. Results: Of 135 students invited to participate, 91 (67.4%) completed the survey. Of these, 10 (7.4% of the invited cohort) also participated in interviews. The mean SUS-score was 75.0 ± 12.0, indicating good usability with room for improvement. Interviews highlighted Edups’ educational relevance, realistic features, and usefulness. Suggested improvements focused on reducing system complexity, improving feature integration and feedback visibility, and providing clearer in-session instructions. Conclusions: Edups bridges a critical gap in medical education by offering a realistic and safe environment to develop prescribing competencies. While participants valued its authenticity and feedback features, targeted usability refinements are required to optimize integration into medical curricula and improve educational impact.
- 20 August 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Open AccessUsability and user experience of an educational electronic prescribing system to train medical students: a mixed-methods approach
Background: Prescribing is a core responsibility of physicians, with electronic (e-)prescribing becoming the global standard. However, e-prescribing is insufficiently integrated in medical curricula, creating a gap between education and actual practice. To address this, we developed Edups, an educational electronic prescribing system that enables medical students to practice prescribing safely in a realistic environment. This study evaluated the usability and user experience of Edups among medical students in a real-world educational setting. Methods: A prospective mixed-methods pilot study was conducted among first- and final-year master’s medical students at Erasmus MC University Medical Center (the Netherlands) from October 2023 to April 2024. In total, 136 students were invited to participate in our study after using Edups during two pharmacotherapy classes. Participants were invited to complete the System Usability Scale (SUS; 5-point Likert scale; 0-100) survey and participate in semi-structured interviews. Data were analyzed using descriptive statistics and inductive thematic analysis. Results: Of 135 students invited to participate, 91 (67.4%) completed the survey. Of these, 10 (7.4% of the invited cohort) also participated in interviews. The mean SUS-score was 75.0 ± 12.0, indicating good usability with room for improvement. Interviews highlighted Edups’ educational relevance, realistic features, and usefulness. Suggested improvements focused on reducing system complexity, improving feature integration and feedback visibility, and providing clearer in-session instructions. Conclusions: Edups bridges a critical gap in medical education by offering a realistic and safe environment to develop prescribing competencies. While participants valued its authenticity and feedback features, targeted usability refinements are required to optimize integration into medical curricula and improve educational impact.
- Open Access
- 5 May 2026
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 48 (5) , 1850-1857
Ketoproof? A systematic classification of pharmaceutical excipients for ketogenic diet therapy
Introduction: Ketogenic diet therapy (KDT) is an evidence-based treatment for refractory epilepsy, particularly in children. Strict adherence to carbohydrate restriction is essential to maintain ketosis, yet many medications contain excipients that can disrupt this balance. Pharmacists play a crucial role in evaluating and adjusting medication regimens for patients on KDT, but limited transparency regarding excipient content often makes this process inefficient and inconsistent. Although some regional databases exist, no systematic and comprehensive resources have been developed for broader use. Aim: This study aimed to systematically classify pharmaceutical excipients and label all medications marketed in the Netherlands according to their compatibility with KDT (“Ketoproof” status) using a transparent, reproducible framework that can serve as the foundation for safer prescribing and international standardization. Method: A retrospective cross-sectional database analysis was conducted using data from the Dutch G-Standaard (June 2023–March 2024), a national pharmaceutical reference database used in the Netherlands. All excipients authorized in medications marketed in the Netherlands were extracted and classified based on chemical composition, metabolic fate, and administration route. Excipients were assigned a Ketoproof status through a structured decision flowchart, expert consensus, and quality control review. Finally, pharmaceutical products were labeled by cross-referencing their excipient profiles against the classified dataset. Results: A total of 1047 excipients were identified. Of these, 778 (74%) were successfully classified: 590 (56%) as Ketoproof and 188 (18%) as non-Ketoproof. The remaining 269 (26%) were unclassified. Excipients requiring expert consensus included polyols and sugar alcohols, organic acids, and coloring and flavoring agents, which were carefully assessed for clinical relevance. Among 28,721 pharmaceutical products analyzed, 41% (n = 11,781) were labeled as Ketoproof. The full dataset was integrated into KetoMed, a web-based tool designed to support healthcare professionals in reviewing medications for patients on KDT. Conclusion: This study presents the first systematic classification of pharmaceutical excipients for KDT compatibility. The transparent, evidence-informed framework enables structured labeling of medications and supports safer prescribing for patients undergoing KDT. Broader adoption and international collaboration are recommended to establish consensus on excipient classification, enhance regulatory transparency, and integrate Ketoproof labeling into clinical decision-support systems to optimize ketogenic therapy management.
- 5 May 2026
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 48 (5) , 1850-1857
Open AccessKetoproof? A systematic classification of pharmaceutical excipients for ketogenic diet therapy
Introduction: Ketogenic diet therapy (KDT) is an evidence-based treatment for refractory epilepsy, particularly in children. Strict adherence to carbohydrate restriction is essential to maintain ketosis, yet many medications contain excipients that can disrupt this balance. Pharmacists play a crucial role in evaluating and adjusting medication regimens for patients on KDT, but limited transparency regarding excipient content often makes this process inefficient and inconsistent. Although some regional databases exist, no systematic and comprehensive resources have been developed for broader use. Aim: This study aimed to systematically classify pharmaceutical excipients and label all medications marketed in the Netherlands according to their compatibility with KDT (“Ketoproof” status) using a transparent, reproducible framework that can serve as the foundation for safer prescribing and international standardization. Method: A retrospective cross-sectional database analysis was conducted using data from the Dutch G-Standaard (June 2023–March 2024), a national pharmaceutical reference database used in the Netherlands. All excipients authorized in medications marketed in the Netherlands were extracted and classified based on chemical composition, metabolic fate, and administration route. Excipients were assigned a Ketoproof status through a structured decision flowchart, expert consensus, and quality control review. Finally, pharmaceutical products were labeled by cross-referencing their excipient profiles against the classified dataset. Results: A total of 1047 excipients were identified. Of these, 778 (74%) were successfully classified: 590 (56%) as Ketoproof and 188 (18%) as non-Ketoproof. The remaining 269 (26%) were unclassified. Excipients requiring expert consensus included polyols and sugar alcohols, organic acids, and coloring and flavoring agents, which were carefully assessed for clinical relevance. Among 28,721 pharmaceutical products analyzed, 41% (n = 11,781) were labeled as Ketoproof. The full dataset was integrated into KetoMed, a web-based tool designed to support healthcare professionals in reviewing medications for patients on KDT. Conclusion: This study presents the first systematic classification of pharmaceutical excipients for KDT compatibility. The transparent, evidence-informed framework enables structured labeling of medications and supports safer prescribing for patients undergoing KDT. Broader adoption and international collaboration are recommended to establish consensus on excipient classification, enhance regulatory transparency, and integrate Ketoproof labeling into clinical decision-support systems to optimize ketogenic therapy management.
- Open Access
- 10 March 2026
- Published by Wolters Kluwer Health in JBI Evidence Implementation
A pain management dashboard in the neonatal intensive care unit: anticipated barriers and facilitators of implementation among health care professionals
Introduction: Neonates in the Neonatal Intensive Care Unit (NICU) frequently experience pain, negatively influencing short- and long-term outcomes. As effective pain management in the NICU is complicated, we developed “a comfort dashboard,” an innovative pain management dashboard. Aim: This study aimed to identify the barriers and facilitators of implementing “a comfort dashboard” in the complex NICU setting to enhance successful adoption and implementation. Methods: A qualitative research design was employed, involving semi-structured interviews with NICU nurses and physicians in a level III−IV NICU. The Consolidated Framework for Implementation Research (CFIR) was applied to identify and analyze barriers and facilitators for implementing “a comfort dashboard.” Results: Interviews with 13 nurses and 5 physicians revealed 21 CFIR constructs, with 4 identified as barriers, 12 as facilitators, and 5 as both. Key facilitators included the dashboard's perceived advantage in enhancing current practices, improving communication between nurses and physicians, and aligning with the NICU's focus on patient comfort. Barriers included concerns about the dashboard's technical complexity and reliability, and the difficulty in reaching all users. Participants emphasized the need for adequate communication and training to achieve user acceptance. Conclusions: The study identified crucial factors influencing the implementation of “a comfort dashboard” in the NICU. Facilitators such as the relative advantage and alignment with existing practices supported its adoption, while barriers such as technical usability and reaching all users needed to be addressed. These insights will guide the development of tailored implementation strategies, aiming to improve pain management and patient outcomes in the NICU. Spanish http://links.lww.com/IJEBH/A513
- 10 March 2026
- Published by Wolters Kluwer Health in JBI Evidence Implementation
Open AccessA pain management dashboard in the neonatal intensive care unit: anticipated barriers and facilitators of implementation among health care professionals
Introduction: Neonates in the Neonatal Intensive Care Unit (NICU) frequently experience pain, negatively influencing short- and long-term outcomes. As effective pain management in the NICU is complicated, we developed “a comfort dashboard,” an innovative pain management dashboard. Aim: This study aimed to identify the barriers and facilitators of implementing “a comfort dashboard” in the complex NICU setting to enhance successful adoption and implementation. Methods: A qualitative research design was employed, involving semi-structured interviews with NICU nurses and physicians in a level III−IV NICU. The Consolidated Framework for Implementation Research (CFIR) was applied to identify and analyze barriers and facilitators for implementing “a comfort dashboard.” Results: Interviews with 13 nurses and 5 physicians revealed 21 CFIR constructs, with 4 identified as barriers, 12 as facilitators, and 5 as both. Key facilitators included the dashboard's perceived advantage in enhancing current practices, improving communication between nurses and physicians, and aligning with the NICU's focus on patient comfort. Barriers included concerns about the dashboard's technical complexity and reliability, and the difficulty in reaching all users. Participants emphasized the need for adequate communication and training to achieve user acceptance. Conclusions: The study identified crucial factors influencing the implementation of “a comfort dashboard” in the NICU. Facilitators such as the relative advantage and alignment with existing practices supported its adoption, while barriers such as technical usability and reaching all users needed to be addressed. These insights will guide the development of tailored implementation strategies, aiming to improve pain management and patient outcomes in the NICU. Spanish http://links.lww.com/IJEBH/A513
- Open Access
- 22 August 2025
- Published by Springer Nature in Intensive Care Medicine – Paediatric and Neonatal
- Vol. 3 (1) , 1-11
Analgosedative prescribing and loading dose strategies in the neonatal intensive care unit: a retrospective cohort study with a focus on hypothermia-treated and extremely premature neonates
Aim: Treating discomfort in neonates is complex, and protocols often lack tailored advice, risking inadequate pain management. This study aims to examine analgosedative prescribing behavior in the Neonatal Intensive Care Unit (NICU) with a focus on the use and impact of loading doses on reducing total cumulative dose and especially in the particularly vulnerable neonates receiving therapeutic hypothermia and those born extremely premature. Methods: This single-center, retrospective study analyzed baseline characteristics and analgosedative administration data from all neonates admitted to our level III-IV NICU between 2017 and 2021. Results: Of the 2633 admissions, 825 neonates (31%) received analgosedation. Among them, 126 (15%) received therapeutic hypothermia and 142 (17%) were born extremely premature. Loading doses were infrequently administered, ranging from 0 to 61% per continuous infusion (re)initiation and dose escalation. Across the cohort, loading doses were associated with a lower total cumulative doses for morphine, but higher for midazolam and fentanyl. Extremely premature neonates receiving morphine continuous infusion with loading doses were followed by lower median starting and maintenance dosages in the most critical first 36 h. Conclusion: Loading doses did not significantly reduce total cumulative exposure to analgosedatives, even increasing it in some cases. However, in extremely premature neonates receiving morphine continuous infusion with loading doses, both the total cumulative dose and the maintenance dose in the first 36-hours were reduced. This indicates that structurally administering loading doses may improve pain management through faster therapeutic effects. Possibly, it could reduce cumulative exposure, if combined with lower initial maintenance dosages and smaller dose-escalation increments.
- 22 August 2025
- Published by Springer Nature in Intensive Care Medicine – Paediatric and Neonatal
- Vol. 3 (1) , 1-11
Open AccessAnalgosedative prescribing and loading dose strategies in the neonatal intensive care unit: a retrospective cohort study with a focus on hypothermia-treated and extremely premature neonates
Aim: Treating discomfort in neonates is complex, and protocols often lack tailored advice, risking inadequate pain management. This study aims to examine analgosedative prescribing behavior in the Neonatal Intensive Care Unit (NICU) with a focus on the use and impact of loading doses on reducing total cumulative dose and especially in the particularly vulnerable neonates receiving therapeutic hypothermia and those born extremely premature. Methods: This single-center, retrospective study analyzed baseline characteristics and analgosedative administration data from all neonates admitted to our level III-IV NICU between 2017 and 2021. Results: Of the 2633 admissions, 825 neonates (31%) received analgosedation. Among them, 126 (15%) received therapeutic hypothermia and 142 (17%) were born extremely premature. Loading doses were infrequently administered, ranging from 0 to 61% per continuous infusion (re)initiation and dose escalation. Across the cohort, loading doses were associated with a lower total cumulative doses for morphine, but higher for midazolam and fentanyl. Extremely premature neonates receiving morphine continuous infusion with loading doses were followed by lower median starting and maintenance dosages in the most critical first 36 h. Conclusion: Loading doses did not significantly reduce total cumulative exposure to analgosedatives, even increasing it in some cases. However, in extremely premature neonates receiving morphine continuous infusion with loading doses, both the total cumulative dose and the maintenance dose in the first 36-hours were reduced. This indicates that structurally administering loading doses may improve pain management through faster therapeutic effects. Possibly, it could reduce cumulative exposure, if combined with lower initial maintenance dosages and smaller dose-escalation increments.
- Open Access
- 23 March 2024
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 91 (8) , 2109-2118
Differences in prescribing errors between electronic prescribing and traditional prescribing among medical students: A randomized pilot study
Aims: This randomized controlled pilot study aimed to assess the differences in the frequency, type and severity of prescribing errors made by medical students when assessed in an electronic (e‐)prescribing system compared to a traditional prescribing method (e.g., typing out a prescription).Methods: Fourth year medical students in the period of 1 November to 31 July 2023, were asked to participate in this single‐centre prospective, randomized, controlled intervention study. Participants performed a prescribing assessment in either an e‐prescribing system (intervention group) or in a more traditional prescribing platform (control group). The prescriptions were checked for errors, graded and categorized. Differences in prescribing errors, error categories and severity were analysed.Results: Out of 334 students, 84 participated in the study. Nearly all participants (98.8%) made 1 or more prescribing errors, primarily involving inadequate information errors. In the intervention group, more participants made prescribing errors involving the prescribed amount (71.4 vs. 19.0%; P < .01), but fewer involving administrative errors (2.4 vs. 19.0%; P = .03). Prescribing‐method‐specific errors were identified in 4.8 and 40.5% of the intervention and control group, respectively, with significant differences in overlapping errors as well.Conclusion: This pilot study shows the importance of training e‐prescribing competencies in medical curricula, in addition to traditional prescribing methods. It identifies prescribing‐method‐specific prescribing errors and emphasizes the need for further research to define e‐prescribing competencies. Additionally, the need for an accessible real‐life‐like e‐prescribing environment tailored to educators and students is essential for effective learning and incorporation of e‐prescribing into medical curricula.
- 23 March 2024
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 91 (8) , 2109-2118
Open AccessDifferences in prescribing errors between electronic prescribing and traditional prescribing among medical students: A randomized pilot study
Aims: This randomized controlled pilot study aimed to assess the differences in the frequency, type and severity of prescribing errors made by medical students when assessed in an electronic (e‐)prescribing system compared to a traditional prescribing method (e.g., typing out a prescription).Methods: Fourth year medical students in the period of 1 November to 31 July 2023, were asked to participate in this single‐centre prospective, randomized, controlled intervention study. Participants performed a prescribing assessment in either an e‐prescribing system (intervention group) or in a more traditional prescribing platform (control group). The prescriptions were checked for errors, graded and categorized. Differences in prescribing errors, error categories and severity were analysed.Results: Out of 334 students, 84 participated in the study. Nearly all participants (98.8%) made 1 or more prescribing errors, primarily involving inadequate information errors. In the intervention group, more participants made prescribing errors involving the prescribed amount (71.4 vs. 19.0%; P < .01), but fewer involving administrative errors (2.4 vs. 19.0%; P = .03). Prescribing‐method‐specific errors were identified in 4.8 and 40.5% of the intervention and control group, respectively, with significant differences in overlapping errors as well.Conclusion: This pilot study shows the importance of training e‐prescribing competencies in medical curricula, in addition to traditional prescribing methods. It identifies prescribing‐method‐specific prescribing errors and emphasizes the need for further research to define e‐prescribing competencies. Additionally, the need for an accessible real‐life‐like e‐prescribing environment tailored to educators and students is essential for effective learning and incorporation of e‐prescribing into medical curricula.
- Open Access
- 22 November 2023
- Published by Wiley
Differences in Prescribing Errors Between Electronic Prescribing and Traditional Prescribing among Medical Students: a randomized pilot study
Aims This randomized controlled pilot study aimed to assess the differences in the frequency, type, and severity of prescribing errors made by medical students when assessed in an electronic prescribing system (EPS) compared to traditional prescribing methods (e.g., writing/typing out a prescription). Methods Fourth year medical students in the period of November 1st to July 31st, 2023, were asked to participate in this single center prospective, randomized, controlled intervention study. Participants performed a prescribing assessment in either an EPS (intervention group) or in a more traditional prescribing platform (control group). The prescriptions were checked for errors, graded, and categorized. Differences in prescribing errors, error categories, and severity were analyzed. Results Out of 334 students, 84 participated in the study. Nearly all participants (98.8%) made one or more prescribing errors, primarily involving inadequate information errors. In the intervention group, more participants made prescribing errors involving the prescribed amount (71.4% vs. 19.0%; P<0.01), but fewer involving administrative errors (2.4% vs. 19.0%; P=0.03). Prescribing-method-specific errors were identified in 4.8% and 40.5% of the intervention and control group, respectively, with significant differences in overlapping errors as well. Conclusions This study shows the importance of training electronic prescribing (e-prescribing) competencies in medical curricula, in addition to traditional prescribing methods. It identifies prescribing-method-specific prescribing errors and emphasizes the need for further research to define e-prescribing competencies. Additionally, the need for an accessible real-life-like e-prescribing environment tailored to educators and students is essential for effective learning and incorporation of e-prescribing into medical curricula.
- 22 November 2023
- Published by Wiley
Open AccessDifferences in Prescribing Errors Between Electronic Prescribing and Traditional Prescribing among Medical Students: a randomized pilot study
Aims This randomized controlled pilot study aimed to assess the differences in the frequency, type, and severity of prescribing errors made by medical students when assessed in an electronic prescribing system (EPS) compared to traditional prescribing methods (e.g., writing/typing out a prescription). Methods Fourth year medical students in the period of November 1st to July 31st, 2023, were asked to participate in this single center prospective, randomized, controlled intervention study. Participants performed a prescribing assessment in either an EPS (intervention group) or in a more traditional prescribing platform (control group). The prescriptions were checked for errors, graded, and categorized. Differences in prescribing errors, error categories, and severity were analyzed. Results Out of 334 students, 84 participated in the study. Nearly all participants (98.8%) made one or more prescribing errors, primarily involving inadequate information errors. In the intervention group, more participants made prescribing errors involving the prescribed amount (71.4% vs. 19.0%; P<0.01), but fewer involving administrative errors (2.4% vs. 19.0%; P=0.03). Prescribing-method-specific errors were identified in 4.8% and 40.5% of the intervention and control group, respectively, with significant differences in overlapping errors as well. Conclusions This study shows the importance of training electronic prescribing (e-prescribing) competencies in medical curricula, in addition to traditional prescribing methods. It identifies prescribing-method-specific prescribing errors and emphasizes the need for further research to define e-prescribing competencies. Additionally, the need for an accessible real-life-like e-prescribing environment tailored to educators and students is essential for effective learning and incorporation of e-prescribing into medical curricula.